News & Updates

Low-dose aspirin does not prevent pre-eclampsia, small birthweight in high-risk women

Among women who are deemed high-risk for pre-eclampsia by Doppler examination, treatment with low-dose aspirin appears to have no significant clinical benefit, a recent study has found.

High intake of various fruits, vegetables lowers cardiometabolic risk factors in older adults

Consumption of a greater variety and quantity of fruits and vegetables (FV) can substantially reduce several cardiometabolic risk factors among older adults at high cardiovascular risk, suggests a study.

Immunotherapy for first-line treatment of NSCLC patients with low PD-L1 expression level (1-49%)

The Need for IO Combination Therapy for Driver Mutation Nagative Non-Squamous Cell Type Patients

Hormone therapy carries risk of slight BP elevations in hypertensive postmenopausal women

The use of hormone therapy poses a small but significant increase in systolic blood pressure (BP) in postmenopausal women with hypertension, a study has found. However, this BP elevation does not lead to increased BP-lowering medication use over time.

Association between PFS2 and Immunotherapy in First-Line Non-Small Cell Lung Cancer (NSCLC)

Asundexian for secondary prevention after acute MI scores high in early trial

The oral activated factor XI (FXIa) inhibitor asundexian, when taken with aspirin plus a P2Y12 inhibitor, appears to facilitate dose-dependent, near-complete inhibition of FXIa activity with a low rate of ischaemic events and without a significant increase in bleeding, according to the results of a phase II trial.